Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 3, 2013, Pages

  Kelly, Patrick ^a,b   Das, Prajnan ^a   Pinnix, Chelsea C ^a   Beddar, Sam ^a   Briere, Tina ^a   Pham, Mary ^a   Krishnan, Sunil ^a   Delclos, Marc E ^a   Crane, Christopher H ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b M D ANDERSON CANCER CENTER ORLANDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EVENTS; CHEMORADIATION; COMMON TERMINOLOGY CRITERIA; CONCURRENT CHEMORADIATION; CONCURRENT CHEMOTHERAPY; COX REGRESSION METHOD; DOSE ESCALATION; HAZARD RATIO; KAPLAN-MEIER; LOCAL CONTROL; MEDICAL RECORD; MULTI VARIATE ANALYSIS; PANCREATIC CANCERS; QUALITY OF LIFE; TREATMENT PLANS; TUMOR LOCATION; UNIVARIATE; UNIVARIATE ANALYSIS;

CHEMORADIOTHERAPY; CHEMOTHERAPY; DISEASES; DOSIMETERS; DOSIMETRY; FAULT TOLERANT COMPUTER SYSTEMS; MULTIVARIANT ANALYSIS; NATURAL LANGUAGE PROCESSING SYSTEMS; PATHOLOGY; QUALITY CONTROL; RADIOTHERAPY;

TOXICITY;

CAPECITABINE; FLUOROURACIL; GEMCITABINE;

ADJUVANT CHEMOTHERAPY; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CONTROLLED STUDY; DUODENITIS; DUODENUM BLEEDING; DUODENUM INJURY; DUODENUM ULCER; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LOCALLY ADVANCED UNRESECTABLE PANCREATIC CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PANCREAS CANCER; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; THROMBOCYTE COUNT; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; DOSE FRACTIONATION; DUODENUM; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RADIATION INJURIES; RADIOTHERAPY DOSAGE;

EID: 84873278759     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.09.035     Document Type: Article

References (20)

1. S. Krishnan, V. Rana, and N.A. Janjan Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy Cancer 110 2007 47 55
2. C.H. Crane, G.R. Varadhachary, and J.S. Yordy Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression J Clin Oncol 29 2011 3037 3043
3. C.P. Li, Y. Chao, and K.H. Chi Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study Int J Radiat Oncol Biol Phys 57 2003 98 104
4. S.P. Desai, E. Ben-Josef, and D.P. Normolle Phase I study of oxaliplatin, full-dose gemcitabine, and concurrent radiation therapy in pancreatic cancer J Clin Oncol 25 2007 4587 4592
5. B. Chauffert, F. Mornex, and F. Bonnetain Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study Ann Oncol 19 2008 1592 1599
6. H.M. Ceha, G. van Tienhoven, and D.J. Gouma Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma Cancer 89 2000 2222 2229
7. C.G. Willett, C.F. Del Castillo, and H.A. Shih Long-term results of intraoperative electron beam irradiation (IOERT) for patients with unresectable pancreatic cancer Ann Surg 241 2005 295 299
8. D. Schellenberg, J. Kim, and C. Christman-Skieller Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 81 2011 181 188
9. J.D. Murphy, C. Christman-Skieller, and J. Kim A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer Int J Radiat Oncol Biol Phys 78 2011 1420 1426
10. A. Nakamura, K. Shibuya, and Y. Matsuo Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer patients treated with gemcitabine-based concurrent chemoradiotherapy Int J Radiat Oncol Biol Phys 84 2012 369 375
11. E.F. Schisterman, N.J. Perkins, and A. Liu Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples Epidemiology 16 2005 73 81
12. B. Emami, J. Lyman, and A. Brown Tolerance of normal tissue to therapeutic irradiation Int J Radiat Oncol Biol Phys 21 1991 109 122
13. B.D. Kavanagh, C.C. Pan, and L.A. Dawson Radiation dose-volume effects in the stomach and small bowel Int J Radiat Oncol Biol Phys 76 2010 S101 S107
14. J. Huang, J.M. Robertson, and Y. Hong Dose-volume analysis of predictors for gastrointestinal toxicity after concurrent full dose gemcitabine and radiotherapy for locally advanced pancreatic adenocarcinoma Int J Radiat Oncol Biol Phys 83 2012 1120 1125
15. J.M. Cosset, M. Henry-Amar, and J.M. Burgers Late radiation injuries of the gastrointestinal tract in the H2 and H5 EORTC Hodgkin's disease trials: emphasis on the role of exploratory laparotomy and fractionation Radiother Oncol 13 1988 61 68
16. H. Kim, H. Lim do, and S.W. Paik Predictive factors of gastroduodenal toxicity in cirrhotic patients after three-dimensional conformal radiotherapy for hepatocellular carcinoma Radiother Oncol 93 2009 302 306
17. C.H. Crane, J.L. Abbruzzese, and D.B. Evans Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? Int J Radiat Oncol Biol Phys 52 2002 1293 1302
18. P.J. Loehrer Sr., Y. Feng, and H. Cardenes Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial J Clin Oncol 29 2011 4105 4112
19. S.J. Taub, and A. Hurley Metallic stents for the treatment of malignant and benign strictures of the biliary system Am J Gastroenterol 92 1997 724 725
20. S.M. Bentzen, L.S. Constine, and J.O. Deasy Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues Int J Radiat Oncol Biol Phys 76 2010 S3 S9